Page last updated: 2024-10-30

metformin and Flatus

metformin has been researched along with Flatus in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
" Another patient on acarbose developed severe hypoglycemia; glycemic control was subsequently maintained on half the baseline dosage of sulfonylurea."2.69Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study. ( Ip, TP; Lam, KS; Tam, SC; Tiu, SC; Tsang, MW, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wolever, TM1
Radmard, R1
Chiasson, JL1
Hunt, JA1
Josse, RG1
Palmason, C1
Rodger, NW1
Ross, SA1
Ryan, EA1
Tan, MH1
Lam, KS1
Tiu, SC1
Tsang, MW1
Ip, TP1
Tam, SC1

Trials

2 trials available for metformin and Flatus

ArticleYear
One-year acarbose treatment raises fasting serum acetate in diabetic patients.
    Diabetic medicine : a journal of the British Diabetic Association, 1995, Volume: 12, Issue:2

    Topics: Acarbose; Acetates; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-

1995
Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study.
    Diabetes care, 1998, Volume: 21, Issue:7

    Topics: Acarbose; Administration, Oral; Blood Glucose; China; Cholesterol; Cholesterol, HDL; Diabetes Mellit

1998